Journal article icon

Journal article

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.

Abstract:

BACKGROUND: Reducing bisphosphonate dosing frequency may improve suboptimal adherence to treatment and therefore therapeutic outcomes in postmenopausal osteoporosis. Once-monthly oral ibandronate has been developed to overcome this problem. OBJECTIVE: To confirm the 1 year results and provide more extensive safety and tolerability information for once-monthly dosing by a 2 year analysis. METHODS: MOBILE, a randomised, phase III, non-inferiority study, compared the efficacy and safety of once-...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1136/ard.2005.044958

Authors


Expand authors...
Journal:
Annals of the rheumatic diseases
Volume:
65
Issue:
5
Pages:
654-661
Publication date:
2006-05-01
DOI:
EISSN:
1468-2060
ISSN:
0003-4967
Source identifiers:
126481

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP